Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party
M Paesmans, J P Sculier, P Libert, et al.
Cancer
|
August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years
M Paesmans, J P Sculier, J Lecomte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, G Bureau, et al.
Revue Des Maladies Respiratoires
|
March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]
J P Sculier, M Paesmans, P Libert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, J Thiriaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, J Thiriaux, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)
M Borges, J P Sculier, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 27, 1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party
J P Sculier, M Paesmans, V Ninane, et al.
International Journal of Oncology
|
May 11, 2011
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer
J Sculier, J Thiriaux, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party
J P Sculier, M Paesmans, J J Lafitte, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party
M Paesmans, J P Sculier, P Libert, et al.
Cancer
|
August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years
M Paesmans, J P Sculier, J Lecomte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, G Bureau, et al.
Revue Des Maladies Respiratoires
|
March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]
J P Sculier, M Paesmans, P Libert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, J Thiriaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, J Thiriaux, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)
M Borges, J P Sculier, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 27, 1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party
J P Sculier, M Paesmans, V Ninane, et al.
International Journal of Oncology
|
May 11, 2011
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer
J Sculier, J Thiriaux, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party
J P Sculier, M Paesmans, J J Lafitte, et al.
Page
of 6